table of content
1 Introduction to Research & Analysis Reports
1.1 Personalized Cancer Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Cancer Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Cancer Vaccines Overall Market Size
2.1 Global Personalized Cancer Vaccines Market Size: 2022 VS 2029
2.2 Global Personalized Cancer Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Cancer Vaccines Players in Global Market
3.2 Top Global Personalized Cancer Vaccines Companies Ranked by Revenue
3.3 Global Personalized Cancer Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Personalized Cancer Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalized Cancer Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Cancer Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Personalized Cancer Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Cancer Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Personalized Cancer Vaccines Market Size Markets, 2022 & 2029
4.1.2 Lung Cancer
4.1.3 Breast Cancer
4.1.4 Colorectal Cancer
4.1.5 Leukemia
4.1.6 Prostate Cancer
4.1.7 Cervical Cancer
4.1.8 Glioblastoma
4.1.9 Others
4.2 By Type - Global Personalized Cancer Vaccines Revenue & Forecasts
4.2.1 By Type - Global Personalized Cancer Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Personalized Cancer Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Cancer Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Personalized Cancer Vaccines Revenue & Forecasts
5.2.1 By Application - Global Personalized Cancer Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Personalized Cancer Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Personalized Cancer Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Personalized Cancer Vaccines Revenue & Forecasts
6.2.1 By Region - Global Personalized Cancer Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Personalized Cancer Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Personalized Cancer Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Personalized Cancer Vaccines Revenue, 2018-2029
6.3.2 US Personalized Cancer Vaccines Market Size, 2018-2029
6.3.3 Canada Personalized Cancer Vaccines Market Size, 2018-2029
6.3.4 Mexico Personalized Cancer Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Personalized Cancer Vaccines Revenue, 2018-2029
6.4.2 Germany Personalized Cancer Vaccines Market Size, 2018-2029
6.4.3 France Personalized Cancer Vaccines Market Size, 2018-2029
6.4.4 U.K. Personalized Cancer Vaccines Market Size, 2018-2029
6.4.5 Italy Personalized Cancer Vaccines Market Size, 2018-2029
6.4.6 Russia Personalized Cancer Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Personalized Cancer Vaccines Market Size, 2018-2029
6.4.8 Benelux Personalized Cancer Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Personalized Cancer Vaccines Revenue, 2018-2029
6.5.2 China Personalized Cancer Vaccines Market Size, 2018-2029
6.5.3 Japan Personalized Cancer Vaccines Market Size, 2018-2029
6.5.4 South Korea Personalized Cancer Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Personalized Cancer Vaccines Market Size, 2018-2029
6.5.6 India Personalized Cancer Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Personalized Cancer Vaccines Revenue, 2018-2029
6.6.2 Brazil Personalized Cancer Vaccines Market Size, 2018-2029
6.6.3 Argentina Personalized Cancer Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Cancer Vaccines Revenue, 2018-2029
6.7.2 Turkey Personalized Cancer Vaccines Market Size, 2018-2029
6.7.3 Israel Personalized Cancer Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Personalized Cancer Vaccines Market Size, 2018-2029
6.7.5 UAE Personalized Cancer Vaccines Market Size, 2018-2029
7 Personalized Cancer Vaccines Companies Profiles
7.1 Advaxis Inc
7.1.1 Advaxis Inc Company Summary
7.1.2 Advaxis Inc Business Overview
7.1.3 Advaxis Inc Personalized Cancer Vaccines Major Product Offerings
7.1.4 Advaxis Inc Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.1.5 Advaxis Inc Key News & Latest Developments
7.2 Personalis
7.2.1 Personalis Company Summary
7.2.2 Personalis Business Overview
7.2.3 Personalis Personalized Cancer Vaccines Major Product Offerings
7.2.4 Personalis Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.2.5 Personalis Key News & Latest Developments
7.3 Hoffmann-La Roche Ltd
7.3.1 Hoffmann-La Roche Ltd Company Summary
7.3.2 Hoffmann-La Roche Ltd Business Overview
7.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.3.5 Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 BioNtech
7.4.1 BioNtech Company Summary
7.4.2 BioNtech Business Overview
7.4.3 BioNtech Personalized Cancer Vaccines Major Product Offerings
7.4.4 BioNtech Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.4.5 BioNtech Key News & Latest Developments
7.5 Celldex
7.5.1 Celldex Company Summary
7.5.2 Celldex Business Overview
7.5.3 Celldex Personalized Cancer Vaccines Major Product Offerings
7.5.4 Celldex Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.5.5 Celldex Key News & Latest Developments
7.6 CureVac AG
7.6.1 CureVac AG Company Summary
7.6.2 CureVac AG Business Overview
7.6.3 CureVac AG Personalized Cancer Vaccines Major Product Offerings
7.6.4 CureVac AG Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.6.5 CureVac AG Key News & Latest Developments
7.7 Genetech
7.7.1 Genetech Company Summary
7.7.2 Genetech Business Overview
7.7.3 Genetech Personalized Cancer Vaccines Major Product Offerings
7.7.4 Genetech Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.7.5 Genetech Key News & Latest Developments
7.8 Genocea
7.8.1 Genocea Company Summary
7.8.2 Genocea Business Overview
7.8.3 Genocea Personalized Cancer Vaccines Major Product Offerings
7.8.4 Genocea Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.8.5 Genocea Key News & Latest Developments
7.9 Gritstone Oncology
7.9.1 Gritstone Oncology Company Summary
7.9.2 Gritstone Oncology Business Overview
7.9.3 Gritstone Oncology Personalized Cancer Vaccines Major Product Offerings
7.9.4 Gritstone Oncology Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.9.5 Gritstone Oncology Key News & Latest Developments
7.10 ISA Pharmaceuticals
7.10.1 ISA Pharmaceuticals Company Summary
7.10.2 ISA Pharmaceuticals Business Overview
7.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Major Product Offerings
7.10.4 ISA Pharmaceuticals Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.10.5 ISA Pharmaceuticals Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Personalized Cancer Vaccines Major Product Offerings
7.11.4 Merck Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Moderna Therapeutics
7.12.1 Moderna Therapeutics Company Summary
7.12.2 Moderna Therapeutics Business Overview
7.12.3 Moderna Therapeutics Personalized Cancer Vaccines Major Product Offerings
7.12.4 Moderna Therapeutics Personalized Cancer Vaccines Revenue in Global Market (2018-2023)
7.12.5 Moderna Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
